午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11974
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

Keliximab 凱利昔單抗 174722-30-6
Flupyrimin N-[(E)-1-(6-氯-3-吡啶基)甲基-2(1H)-吡啶亞基]-2,2,2-三氟乙酰胺 1689566-03-7
Obexelimab 奧貝利單抗 1690307-05-1
Gosuranemab 1788032-39-2
Odronextamab 奧尼妥單抗 1801338-64-6
WAY-639228 N-(1-芐基哌啶-4-基)萘-2-磺酰胺 179051-05-9
Basiliximab 巴利昔單抗 179045-86-4
AZ-PFKFB3-67 (2S)-N-[4-[[3-Cyano-1-[(3,5-dimethyl-4-isoxazolyl)methyl]-1H-indol-5-yl]oxy]phenyl]-2-pyrrolidinecarboxamide 1704741-11-6
FK 866 hydrochloride (658084-64-1 free base) N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide Hydrochloride 1785666-54-7
BCAT-IN-2 BCAT-IN-2 1800024-45-6
GNE-0946 GNE-0946 1677667-24-1
Porgaviximab Porgaviximab 1792982-55-8
LDN-209929 dihydrochloride 化合物 LDN-209929 DIHYDROCHLORIDE 1784281-97-5
PG 34 化合物 PG 34 1681056-62-1
Netakimab Netakimab 1796570-08-5
Igovomab 伊戈伏單抗 171656-50-1
RN-1665 化合物 RN-1665 1803003-65-7
NLRP3/AIM2-IN-3 化合物 NLRP3/AIM2-IN-3 1787787-60-3
Felvizumab Felvizumab 167747-20-8
Propofol-d17 β-D glucuronide 丙泊酚-D17Β-D-葡糖醛酸 1683581-05-6
tert-Butyl (6-iodohexyl)carbamate TERT-BUTYL 6-IODOHEXYLCARBAMATE 172846-36-5
SXC 2023 (R)-2-乙酰氨基-3-((4-甲基苯甲酰基)硫基)丙酸 1695562-36-7
Elezanumab Elezanumab 1791416-49-3
Larcaviximab Larcaviximab 1792982-56-9
SR12418 化合物 SR12418 1801185-08-9
CCT245232 化合物 CCT245232 1693731-14-4
RYL-552S 化合物 RYL-552S 1801444-69-8
Inophyllum E 紅厚殼（種）內(nèi)酯 17312-31-1
Anisperimus 阿珀莫司 170368-04-4
SR4554 SR4554 167648-73-9
Sarizotan 2HCl SARIZOTAN 2鹽酸鹽 177976-12-4
Phenmedipham-d3 甜菜寧-D3 1773497-41-8
Rosmantuzumab Rosmantuzumab 1684393-04-1
Emapalumab 依瑪魯單抗 1709815-23-5
ATX-002 ATX-002 1777792-34-3
GSK180 GSK180 1799725-26-0
GNF6702 GNF-6702 1799329-72-8
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid AA 174603-37-3
Frunevetmab 夫盧維單抗 1708936-80-4
Cemiplimab Cemiplimab 1801342-60-8
BODIPY FL prazosin 化合物 BODIPY FL PRAZOSIN 175799-93-6
Nav1.7-IN-3 NAV1.7-IN-3 1788872-06-9
Remtolumab 壬托魯單抗 1791410-27-9
Lutikizumab Lutikizumab 1791411-57-8
Telisotuzumab Telisotuzumab 1781223-80-0
Oleclumab 奧來魯單抗 1803176-05-7
Cevidoplenib Methanone, cyclopropyl[5-[[4-[4-[[(4S)-4-hydroxy-2-isoxazolidinyl]methyl]-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-1-methyl-1H-indol-3-yl]- 1703788-21-9
DJ4 化合物DJ4 1681020-24-5
DP00477 化合物 DP00477 169120-56-3
(2R,5S)-Ritlecitinib 1792180-79-0 1792180-79-0
αvβ1 integrin-IN-1 化合物 T13473 1689540-62-2
Sacituzumab 沙西妥珠單抗 1796566-95-4
Crizanlizumab Crizanlizumab 1690318-25-2
Cosfroviximab Cosfroviximab 1792982-57-0
Gremubamab GREMUBAMAB (格瑞巴單抗 ) 1800381-36-5
Xanthine amine congener hydrochloride N-(2-氨基乙基)-2-(4-(2,6-二氧代-1,3-二丙基-2,3,6,7-四氫-1H-嘌呤-8-基)苯氧基)乙酰胺鹽酸鹽 1783977-95-6
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc THALIDOMIDE-O-AMIDO-CH2-PEG3-CH2-NH-BOC 1799711-31-1
Dyrk1A-IN-5 化合物 DYRK1A-IN-5 1685235-41-9
Lanepitant 拉奈匹坦 170566-84-4
Opaviraline 奧帕韋蘭 178040-94-3
NLRP3-IN-13 NLRP3 抑制劑 13 1704638-35-6
RKI-1447 dihydrochloride RKI 1447 dihydrochloride 1782109-09-4
NDH-1 inhibitor-1 N-(3,4-二甲氧基芐基)-2-萘甲酰胺 173964-49-3
Vunakizumab Vunakizumab 1792181-33-9
Losatuxizumab Losatuxizumab 1801544-27-3
Dilpacimab Dilpacimab 1791420-09-1
Minzasolmin 化合物 MINZASOLMIN 1802518-92-8
GPR40 agonist 6 化合物 GPR40 AGONIST 6 1798751-25-3
ER-34122 化合物 ER-34122 179325-62-3
(R)-VX-11e (R)-4-(2-((2-氯-4-氟苯基)氨基)-5-甲基嘧啶-4-基)-N-(1-(3-氯苯基)-2-羥基乙基)-1H-吡咯-2-甲酰胺 1680187-43-2
Ravulizumab Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer 1803171-55-2
Roxifiban acetate 化合物 T24733 176022-59-6
Lanepitant 2HCl 拉奈匹坦鹽酸鹽 170508-05-1
Nonabine 諾大麻 16985-03-8
Tidembersat TIDEMBERSAT 175013-73-7
Izonsteride IZONSTERIDE 176975-26-1
YM-58790 化合物YM-58790 168830-70-4
CYP1B1-IN-5 CYP1B1抑制劑5 176442-56-1
SB-237376 HCl Benzamide, N-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro-, hydrochloride (1:1) 179258-62-9
Piprozolin 哌普唑林 17243-64-0
3,4,5-Trihydroxycinnamic acid decyl ester 化合物 3,4,5-TRIHYDROXYCINNAMIC ACID DECYL ESTER 1770778-45-4
Cynandione A 1,1'-(2',3,6,6'-四羥基-[1,1'-聯(lián)苯]-2,3'-二基)二乙酮 168706-29-4
1-vinylpyrene 1-乙烯 17088-21-0
Oleoylestrone 雌酮 3-油酸酯 180003-17-2
Sodium zirconium cyclosilicate 環(huán)硅酸鋯鈉 17141-74-1
ZY-444 化合物 ZY-444 1802650-31-2
Vutiglabridin 化合物 VUTIGLABRIDIN 1800188-47-9
ML 120B dihydrochloride MLN120B DIHYDROCHLORIDE 1782573-78-7
Faralimomab Faralimomab 167816-91-3
MMP2-IN-2 5-硝基-2-(4-硝基苯基)-1H-苯并咪唑 1772-39-0
KL044 9H-Carbazole-9-acetamide, N-(2-chloro-6-cyanophenyl)- 1801856-93-8
UC-781 N-[4-chloro-3-(3-methylbut-2-enoxy)phenyl]-2-methyl-furan-3-carbothioamide 178870-32-1
Tagatose 化合物 T34770 17598-81-1
ARTD10/PARP10-IN-1 ARTD10/PARP10抑制劑1 1708103-76-7
ABBV-318 ABBV-318 1802848-94-7
PF-04822163 化合物 T28367 1798334-07-2
RYL-552 化合物 T28636 1801444-56-3
SB-237376 化合物 SB-237376 179258-59-4
Sulesomab 硫索單抗 167747-19-5
BMS-599626 2HCL(714971-09-2 Free base) 化合物 BMS-599626 2HCL(714971-09-2 FREE BASE) 1781932-33-9
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.